Centrul medical Focus
Bucuresti, Romania
Public medical center in Bucharest
Apartment Building A, Bulevardul Ferdinand I 141, București 021389
About Centrul medical Focus
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Merck Sharp & Dohme LLC
2
EMD Serono Research & Development Institute, Inc.
1
Clinical Trials at Centrul medical Focus
During the past decade, Centrul medical Focus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
2019-06-28
2024-12-30
Active, not recruiting
1,005
A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)
2019-06-28
2024-12-30
Active, not recruiting
857
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
2022-04-14
2027-10-01
Recruiting
900
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
2022-10-06
2030-12-16
Recruiting
700
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
2022-10-04
2032-03-15
Recruiting
6,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrul medical Focus"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centrul medical Focus
According to Clinical.Site data, the most researched conditions in "Centrul medical Focus" are
"Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Centrul medical Focus" in a lesser frequency.
Clinical Trials Intervention Types at Centrul medical Focus
Most popular intervention types in "Centrul medical Focus" are "Drug" (5 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Olaparib" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centrul medical Focus
The vast majority of trials in "Centrul medical Focus" are
4 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Centrul medical Focus
Currently, there are NaN active trials in "Centrul medical Focus".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Centrul medical Focus,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrul medical Focus, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".